Endoscopy Department GEA, Sahlgrenska university Hospital
Gothenburg, S-413 45, Sweden
NCT Number: NCT02845258
Patients may evolve pseudocysts of the pancreas secondary to a severe pancreatitis. In case of a symptomatic or infected pseudocyst, a therapeutic drainage of the cyst is indicated. In modern medicine the preferred way to perform such a drainage is by the means of endoscopic ultrasound (EUS). It is not precisely elucidated how this EUS-procedure should be performed in different scenarios. The cyst appearance and the drainage stents and/or technique may impact the clinical outcome.
This study is a prospective, single-center observational study on the outcome after EUS-guided drainage of pancreatic pseudocysts.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Gothenburg, S-413 45, Sweden
Patintes referred to Sahlgrenska University hospital for an EUS-guided drainage of a pseudocyst are eligible for inclusion. The drainage is performed at the discretion of an experienced endosonographer. Thus, the equipment and the technique used may vary among patients but no randomization is done before the procedure. Intraprocedural variables are registered as well as data and outcome parameters from the clinical follow up according to below.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pancreatic pseudocyst drainage with a plastic or self-expandable metallic stent (SEMS):
This procedure is to be regarded as a clinical routine procedure since a couple of years back. The type of stent (material? length? thickness?), the cyst appearance (large? infected? cyst wall thickness?) and the type of access (transgastric? transduodenal?) may however vary from patient to patient.
In this study we perform EUS-drainage using different types of equipment on a wide range of pancreatic pseudocysts of different appearance and character. All procedures are performed as recommended. The very aim of the study is to investigate which technique and Equipment is to be preferred in different scenarios.
Time frame: Uo to 48 hours
The number of EUS-procedure-related complications such as bleeding, infection and death.
Time frame: Up to 3 months
A successful drainage means no need for additional drainage procedures. The need for a repeated drainage is to be regarded as a therapeutic failure. The number of repeated procedures due to the need for additional drainage is recorded.
Time frame: Up to 30 days
The number of days spent in hospital post-EUS-drainage
Time frame: Up to 6 months
Infections and other complications related to the non-complete drainage of the pseudocyst after discharge from the hospital
Sahlgrenska University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03147768
Adenocarcinoma, Adenoma
Houston, Texas, United States
View Trial DetailsNCT03797209
Cysts, Digestive System Diseases
Nagakute-Shi, Aichi-ken, Japan
View Trial DetailsNCT03002051
Acute Cholecystitis, Biliary Obstruction
Hong Kong, China
View Trial DetailsNCT02730663
Cysts, Digestive System Diseases
Bucheon-si, Gyeonggi-do, South Korea
View Trial Details